Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 125 (RN7SKP125) is classified as a pseudogene related to the 7SK small nuclear RNA, which itself is a regulatory noncoding RNA involved in transcription control through modulation of the elongation factor P-TEFb and as an RNA scaffold recruiting numerous RNA-binding proteins important for neuronal differentiation, gene regulation, mRNA metabolism, and ribosome biogenesis. However, as a pseudogene, RN7SKP125 is not expected to encode a functional molecule, nor is it established as a therapeutic or biological target, and there is no evidence of its direct biological function, disease association, drug interaction, biomarker role, or safety profile in the literature. 7SK snRNA is a master regulator of transcriptional elongation, especially important in neurons, serving as a scaffold for complexes that regulate gene expression, mRNA processing, and ribosome biogenesis. RN7SK pseudogenes are genomic sequences resembling the functional 7SK snRNA gene but do not produce functional RNA. Pseudogenes typically arise from gene duplication or retrotransposition events and are usually nonfunctional, though rarely they may have regulatory roles (not documented for RN7SKP125). Therapeutic relevance: Pseudogenes such as RN7SKP125 are not considered drug targets, receptors, enzymes, or similar entities, and are not cited in current research as having any functional role, therapeutic relevance, or disease mechanism. The information provided here is distinct from functional 7SK snRNA, which itself is a key noncoding RNA for transcriptional regulation, but RN7SKP125 refers specifically to a pseudogene variant, not the active molecule. If your interest lies in the functional 7SK snRNA, the descriptions above describe its role as a transcriptional regulator and scaffold for large RNA-protein complexes central to neuronal differentiation and homeostasis, but RN7SKP125 itself does not map to any known functional molecule or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 125 (RN7SKP125).